INTERNATIONAL PATENT: CANTAI THERAPEUTICS INC. FILES APPLICATION FOR "ENGINEERED BISPECIFIC MOLECULES AND METHODS OF USE"

GENEVA, June 4 -- CANTAI THERAPEUTICS INC. (3675 Market Street, Suite 200Philadelphia, Pennsylvania 19104) filed a patent application (PCT/US2024/057167) for "ENGINEERED BISPECIFIC MOLECULES AND METHODS OF USE" on Nov 22, 2024. With publication no. WO/2025/111585, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VEMURI, Geeta (c/o Cantai Therapeutics Inc.3675 Market Street, Suite 200Philadelphia, Pennsylvania 19104)

Abstract: Provided herein are bispecific molecules and methods of treating using the bispecific molecules...